Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Robert, Daber"'
Autor:
Kara N. Maxwell, Bradley Wubbenhorst, Brandon M. Wenz, Daniel De Sloover, John Pluta, Lyndsey Emery, Amanda Barrett, Adam A. Kraya, Ioannis N. Anastopoulos, Shun Yu, Yuchao Jiang, Hao Chen, Nancy R. Zhang, Nicole Hackman, Kurt D’Andrea, Robert Daber, Jennifer J. D. Morrissette, Nandita Mitra, Michael Feldman, Susan M. Domchek, Katherine L. Nathanson
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
Most tumours associated with germline BRCA1/BRCA2 loss of function mutations respond to DNA damaging agents, however, some do not. Herein, the authors identify that a subset of breast/ovarian tumors retain a normal allele, which is associated with de
Externí odkaz:
https://doaj.org/article/0f6f94b247c0462089e5fb392de747ba
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Supplemental Figure S1. Patient flow diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c3aef36f1dc12f778f992b823a999e
https://doi.org/10.1158/1078-0432.22460405
https://doi.org/10.1158/1078-0432.22460405
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Purpose: DNA methyltransferase 3A (DNMT3A) is one of the commonly mutated genes in acute myelogenous leukemia (AML). Reports on the prognostic significance of DNMT3A mutations have been inconsistent, and most of the data are available only for patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::413618039935bc8d0919d30ca836ebda
https://doi.org/10.1158/1078-0432.c.6524483
https://doi.org/10.1158/1078-0432.c.6524483
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Supplemental Table S1. Frequency of DNMT3A mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482d913e57c02bf12b6c4e7d8baa3a0e
https://doi.org/10.1158/1078-0432.22460399.v1
https://doi.org/10.1158/1078-0432.22460399.v1
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Supplementary Table and Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28d3a0867eee88643e9a7d45580718e
https://doi.org/10.1158/1078-0432.22460393.v1
https://doi.org/10.1158/1078-0432.22460393.v1
Autor:
Isaac Garcia-Murillas, Giselle Walsh-Crestani, Edward Phillips, Rosalind Cutts, Sarah Hrebien, Kathryn Dunne, Kally Sidhu, Robert Daber, Amber C. Carter, Lorena De La Peña, Stephen Johnston, Alistair Ring, Simon Russell, Abigail Evans, Anthony Skene, Duncan Wheatley, Ian Smith, Nicholas Turner
Publikováno v:
Cancer Research. 83:P5-05
Introduction: Identification of Molecular Residual Disease (MRD) in patients with breast cancer with circulating tumor DNA (ctDNA) presents a strategy to identify patients at high risk of relapse. Approaches that detect ctDNA at lower concentrations
Autor:
Elizabeth M. Azzato, Anders Meyer, Carmela Paolillo, Robyn T. Sussman, Jason N. Rosenbaum, Robert Daber, David B. Lieberman, Ashkan Bigdeli, Sydney M. Shaffer, Karthik Ganapathy, Jennifer J.D. Morrissette, Midhat S. Farooqi, Shrey Sukhadia, Daniel DeSloover
Publikováno v:
Cancer Genetics. :55-63
One caveat of next-generation sequencing (NGS)-based clinical oncology testing is the high amount of input DNA required. We sought to develop a focused NGS panel that could capture hotspot regions in relevant genes requiring 0.5-10 ng input DNA. The
Autor:
Zev A. Binder, Derek A. Oldridge, Arati Desai, Steven Brem, Jacquelyn J. Roth, Christopher D. Watt, Robert Daber, Eva Klinman, MacLean Nasrallah, Shrey Sukhadia, David B. Lieberman, Jennifer J.D. Morrissette, Donald M. O'Rourke, Jianhua Zhao
Publikováno v:
Academic Pathology, Vol 6 (2019)
Academic Pathology
Academic Pathology
Molecular profiling of glioblastoma has revealed complex cytogenetic, epigenetic, and molecular abnormalities that are necessary for diagnosis, prognosis, and treatment. Our neuro-oncology group has developed a data-driven, institutional consensus gu
Autor:
Robert Daber, Mathew S. Maurer, Stephen Helmke, Daniel P. Judge, Jianhua Zhao, Megan Hawley, Marc Grodman, Sergio Teruya, Sam Harris, Hannah Rosenblum, Sarah Godfrey, Jan M. Griffin, Harpreet Gill
Publikováno v:
Journal of the American College of Cardiology. 77:3305
Autor:
Jason D. Peterson, Robin D. Harrington, Lorn Davis, Bharathi Anekella, Andrea Ferreira-Gonzalez, Gregory J. Tsongalis, Vishal Kumar Sarsani, Helen Fernandes, Stephen Haralampu, Yves Konigshofer, Catherine Huang, Catherine I. Dumur, Vanessa Spotlow, Francine B. de Abreu, Robert Daber, Russell K. Garlick, Courtney H. Bouk, Chih-Jian Lih, P. Mickey Williams, Sophie J. Deharvengt
Publikováno v:
The journal of applied laboratory medicine. 2(2)
Background Next-generation sequencing (NGS) assays are highly complex tests that can vary substantially in both their design and intended application. Despite their innumerous advantages, NGS assays present some unique challenges associated with the